News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

DARA BioSciences, Inc. Will Present at Singular Research Conference November 1



10/30/2012 7:51:36 AM

RALEIGH, N.C.--(BUSINESS WIRE)--DARA BioSciences, Inc. (NASDAQ: DARA), a specialty pharmaceutical company focused on oncology and oncology supportive care products, announced today it will present at the Singular Research seventh annual “Best of the Uncovereds” Conference on Thursday, November 1 in Los Angeles. DARA just launched its second product in five months (Soltamox®, the only FDA-approved oral liquid version of tamoxifen citrate), and is planning a third product launch for first quarter of 2013.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES